Qualigen Therapeutics, Inc. enterprise value

The Enterprise Value as of October 2026 (TTM) for Qualigen Therapeutics, Inc. (QLGN) is 21.73M

According to Qualigen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 21.73M. This represents a change of -620.73% compared to the average of -4173380.60 of the last 4 quarters.

Qualigen Therapeutics, Inc. (QLGN) Historical Enterprise Value (quarterly & annually)

How has QLGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Qualigen Therapeutics, Inc. over the last ten years is 58.37M. The current 21.73M Enterprise Value has changed -62.77% with respect to the historical average. Over the past ten years (40 quarters), QLGN's Enterprise Value was at its highest in in the March 2019 quarter at 133.88M. The Enterprise Value was at its lowest in in the September 2025 quarter at -31989953.32.

Qualigen Therapeutics, Inc. (QLGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Qualigen Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Qualigen Therapeutics, Inc. (QLGN) Average Enterprise Value

How has QLGN Enterprise Value performed in the past?

The current Enterprise Value of Qualigen Therapeutics, Inc. (QLGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Qualigen Therapeutics, Inc. (QLGN) Enterprise Value vs. Peers

How is QLGN’s Enterprise Value compared to its peers?

Qualigen Therapeutics, Inc.’s Enterprise Value is greater than Soligenix, Inc. (-1729570.00), greater than Oragenics, Inc. (-2189346.00), greater than Titan Pharmaceuticals, Inc. (-962561.00), greater than Can-Fite BioPharma Ltd. (756.02K), greater than Xenetic Biosciences, Inc. (-1316770.00), greater than Kazia Therapeutics Ltd ADR (-50252369.36), greater than Ensysce Biosciences, Inc. (7.30M), greater than CNS Pharmaceuticals, Inc. (-13393860.00), greater than Clearmind Medicine Inc. (-7085967.00), greater than KALA BIO, Inc. (3.08M),

Build a custom stock screener for Qualigen Therapeutics, Inc. (QLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qualigen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Qualigen Therapeutics, Inc. (QLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Qualigen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.